Combination therapy with ruxolitinib plus 5‐azacytidine or continuous infusion of low dose cytarabine is feasible in patients with blast‐phase myeloproliferative neoplasms. (22nd July 2014) - Mwirigi, Anne; Galli, Sofia; Keohane, Clodagh; Raj, Kavita; Radia, Deepti H.; Harrison, Claire N.; McLornan, Donal P.